Sarms Powder Gw-501516 Fitness Cardarine Gw501516 GSK-516 for Bodybuilding Supplement
About GW501516
GW501516 Product Name: GW501516
GW501516 Synonyms: 2-(4-((2-(4-(TRIFLUOROMETHYL)PHENYL)-5-METHYLTHIAZOL-4-YL)METHYLTHIO)-2-METHYLPHENOXY)ACETIC ACID; 2-[2-Methyl-4-[[[4-methyl-2-[4-(trifluoromethyl)phenyl]-5-thiazolyl]methyl]thio]phenoxy]acetic Acid; Methyl-methyl-trifluoromethylphenyl -thiazolyl-methylsulfanyl-phenoxy-acetic Acid; 2-(4-((2-(4-(trifluoromethyl)phenyl)-4-methylthiazol-5-yl)methylthio)-2-methylphenoxy)acetic acid; GW 1516; 2-(2-methyl-4-((5-methyl-2-(4-(trifluoromethyl)phenyl)thiazol-4-yl)methylthio)phenoxy)acetic acid; GW501516, Free Acid; GSK-516
GW501516 CAS: 317318-70-0
GW501516 MF: C21H18F3NO3S2
GW501516 MW: 453.5
GW501516 EINECS:Â
GW501516 Product Categories: Intermediates & Fine Chemicals; Pharmaceuticals; Sulfur & Selenium Compounds; kl; Inhibitor; Antineoplastic; SARMs(Selective androgen receptor modulator); Inhibitors
GW501516 Mol File: 317318-70-0. mol
Check it Before You Use
GW501516 (also known as GW-501,516, GW1516, GSK-516 and Endurobol)is a PPARδ receptor.
It activates the same pathways activated through exercise, including PPARδ and AMP-activated protein kinase. It had been investigated as a potential treatment for obesity, diabetes, dyslipidemia and cardiovascular disease. GW501516 has a synergistic effect when combined with AICAR: the combination has been shown to significantly increase exercise endurance in animal studies more than either compound .
GW501516 Liquid Dosage
GW501516 Half life is between 16-24 hours and should be take at 10mg once a day or 10mg once every 10-12 hours if taken at a higher dose.Â
Â
GW501516Â Â Function:
GW501516 could be used by athletes as an ergogenic performance enhancing drug that was notÂ
currently controlled by regulations or detected by standard tests. One of the main researchers from the study onenhanced endurance consequently developed a urine test to detect the drug, and made it available to the International Olympic Committee.Â
Other SARMs
Â
Name | CAS NO. | Usage |
AICAR | 2627-69-2 | acts by entering nucleoside pools, significantly increasing levels of adenosine during periods of ATP breakdown |
MK2866 | 841205-47-8 | medical prescription for prevention of cachexia, atrophy, and sarcopenia and for Hormone or Testoserone Replacement Therapy. |
MK-677 | 15972-10-0 | Â for the treatment of frailty in the elderly |
LGD-4033 | 1165910-22-4 | pharmacological profile similar to that of enobosarm, Ostarine,MK-2866 |
GW1516 | 317318-70-0 | For obesity, diabetes, dyslipidemia and cardiovascular disease |
Andarine(S4) | 401900-40-0 | partial agonist, intended mainly for treatment of benign prostatic hypertrophy |
SR9009 | 1379686-30-2 | under development at The Scripps Research Institute (TSRI), increases the level of metabolic activity in skeletal muscles of mice |
RAD140 | 1182367-47-0 | New generation for gaining mass and cutting edges |
YK11 | 431579-34-9 | YK11: a SARM and myostatin inhibitor in one  |
AC262356 | 870888-46-3 | New SARMS |
SR9011 | 1379686-29-9 | New SARMS |
S23 | 1010396-29-8 | New SARMS |
GW0724 | 317318-84-6 | New SARMS |
Â
About GW501516
GW501516 Product Name: GW501516
GW501516 Synonyms: 2-(4-((2-(4-(TRIFLUOROMETHYL)PHENYL)-5-METHYLTHIAZOL-4-YL)METHYLTHIO)-2-METHYLPHENOXY)ACETIC ACID; 2-[2-Methyl-4-[[[4-methyl-2-[4-(trifluoromethyl)phenyl]-5-thiazolyl]methyl]thio]phenoxy]acetic Acid; Methyl-methyl-trifluoromethylphenyl -thiazolyl-methylsulfanyl-phenoxy-acetic Acid; 2-(4-((2-(4-(trifluoromethyl)phenyl)-4-methylthiazol-5-yl)methylthio)-2-methylphenoxy)acetic acid; GW 1516; 2-(2-methyl-4-((5-methyl-2-(4-(trifluoromethyl)phenyl)thiazol-4-yl)methylthio)phenoxy)acetic acid; GW501516, Free Acid; GSK-516
GW501516 CAS: 317318-70-0
GW501516 MF: C21H18F3NO3S2
GW501516 MW: 453.5
GW501516 EINECS:Â
GW501516 Product Categories: Intermediates & Fine Chemicals; Pharmaceuticals; Sulfur & Selenium Compounds; kl; Inhibitor; Antineoplastic; SARMs(Selective androgen receptor modulator); Inhibitors
GW501516 Mol File: 317318-70-0. mol
Check it Before You Use
GW501516 (also known as GW-501,516, GW1516, GSK-516 and Endurobol)is a PPARδ receptor.
It activates the same pathways activated through exercise, including PPARδ and AMP-activated protein kinase. It had been investigated as a potential treatment for obesity, diabetes, dyslipidemia and cardiovascular disease. GW501516 has a synergistic effect when combined with AICAR: the combination has been shown to significantly increase exercise endurance in animal studies more than either compound .
GW501516 Liquid Dosage
GW501516 Half life is between 16-24 hours and should be take at 10mg once a day or 10mg once every 10-12 hours if taken at a higher dose.Â
Â
GW501516Â Â Function:
GW501516 could be used by athletes as an ergogenic performance enhancing drug that was notÂ
currently controlled by regulations or detected by standard tests. One of the main researchers from the study onenhanced endurance consequently developed a urine test to detect the drug, and made it available to the International Olympic Committee.Â
Other SARMs
Â
Name | CAS NO. | Usage |
AICAR | 2627-69-2 | acts by entering nucleoside pools, significantly increasing levels of adenosine during periods of ATP breakdown |
MK2866 | 841205-47-8 | medical prescription for prevention of cachexia, atrophy, and sarcopenia and for Hormone or Testoserone Replacement Therapy. |
MK-677 | 15972-10-0 | Â for the treatment of frailty in the elderly |
LGD-4033 | 1165910-22-4 | pharmacological profile similar to that of enobosarm, Ostarine,MK-2866 |
GW1516 | 317318-70-0 | For obesity, diabetes, dyslipidemia and cardiovascular disease |
Andarine(S4) | 401900-40-0 | partial agonist, intended mainly for treatment of benign prostatic hypertrophy |
SR9009 | 1379686-30-2 | under development at The Scripps Research Institute (TSRI), increases the level of metabolic activity in skeletal muscles of mice |
RAD140 | 1182367-47-0 | New generation for gaining mass and cutting edges |
YK11 | 431579-34-9 | YK11: a SARM and myostatin inhibitor in one  |
AC262356 | 870888-46-3 | New SARMS |
SR9011 | 1379686-29-9 | New SARMS |
S23 | 1010396-29-8 | New SARMS |
GW0724 | 317318-84-6 | New SARMS |
Â
Qc Test,Blood Glucose Qc,Blood Glucose Test Qc,Glycohemoglobin Qc Solution
Wuxi BioHermes Bio & Medical Technology Co., Ltd. , https://www.biohermesglobal.com